Sen. Charles Grassley, the ranking Republican on the Senate Finance Committee, says that the FDA’s Drug Safety Oversight Board voted 8-7 on Oct. 2 to keep the scandal-plagued diabetes drug Avandia on the market. The result was kept from the public.
Wow, what a nailbiter. That’s enough to give Glaxo execs a heart attack (or at least increase the risk of one by, oh, 43 percent.)
(Via Reuters.)
1 response so far ↓
1 Dan // Mar 9, 2008 at 7:23 pm
Grassley appears to be one of our greater allies. Did you know he provides his own personal fax line on his website for potential whistleblowers?
Leave a Comment